Flumadine (Caraco Pharma, Inc.)
Welcome to the PulseAid listing for the Flumadine drug offered from Caraco Pharma, Inc.. This Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Caraco Pharma, Inc. |
NON-PROPRIETARY NAME: | flumadine |
SUBSTANCE NAME: | RIMANTADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-09-22 |
END MARKETING DATE: | 0000-00-00 |
Flumadine HUMAN PRESCRIPTION DRUG Details:
Item Description | Flumadine from Caraco Pharma, Inc. |
LABELER NAME: | Caraco Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2009-09-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49708-521_3f2752c1-89c7-483d-a974-e47b75ffa259 |
PRODUCT NDC: | 49708-521 |
APPLICATION NUMBER: | NDA019649 |
Other RIMANTADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: